Sage Journals: Discover world-class research

Free access

Research article

First published 2007-11

A Novel Phosphodiesterase Type 4 Inhibitor,HT-0712,Enhances Rehabilitation-Dependent Motor Recovery and Cortical Reorganization After Focal Cortical Ischemia

Erin MacDonald, Heidi Van der Lee, David Pocock [...]

Neurorehabilitation and Neural Repair

Open access

Research article

First published 2021-9

Preliminary evidence for the phosphodiesterase type-4 inhibitor,roflumilast,in ameliorating cognitive flexibility deficits in patients with schizophrenia

Nicholas R Livingston, Peter CT Hawkins, James Gilleen [...]

Journal of Psychopharmacology

Retricted access

Research article

First published 2021-1

The effects of roflumilast,a phosphodiesterase type-4 inhibitor,on EEG biomarkers in schizophrenia: A randomised controlled trial

James Gilleen, Judith Nottage, Farah Yakub [...]

Journal of Psychopharmacology

Retricted access

Other

First published 2009-10

Treatment with the phosphodiesterase type-4 inhibitor rolipram fails to inhibit blood—brain barrier disruption in multiple sclerosis

Bibiana Bielekova, Nancy Richert, Thomas Howard [...]

Multiple Sclerosis Journal

Free access

Research article

First published 2012-6

Effect of rolipram,a phosphodiesterase enzyme type– 4 inhibitor,on γ-amino butyric acid content of the frontal cortex in mice exposed to chronic mild stress

Amany Mohamed Shalaby, Sahar Mohamed Kamal

Journal of Pharmacology and Pharmacotherapeutics

Free access

Research article

First published 2015-2

Phosphodiesterase Inhibitory Activity of the Flavonoids and Xanthones from Anaxagorea luzonensis

Chalisa Sabphon, Prapapan Temkitthawon, Kornkanok Ingkaninan [...]

Natural Product Communications

Retricted access

Research article

First published 2013-11

Persistent cAMP Signaling by TSH Receptors Revealed by Phosphodiesterase Inhibition

Elizabeth Geras-Raaka, Susanne Neumann, Marvin C. Gershengorn

Thyroid®

Free access

Research article

First published 2020-6

A Novel Inhibition Modality for Phosphodiesterase 2A

Kosuke Nakashima, Hideki Matsui

Journal of Biomolecular Screening

Free access

Review article

First published 2010-10

Apremilast: a novel PDE4 inhibitor in the treatment of autoimmune and inflammatory diseases

Georg Schett, Victor S. Sloan, Randall M. Stevens [...]

Therapeutic Advances in Musculoskeletal Disease

Retricted access

Research article

First published 1978-11

Effect of a Phosphodiesterase Inhibitor,3-lsobutyl 1-methylxanthine,upon the Stimulatory Effect of Human Follicle-Stimulating Hormone and Human Luteinizing Hormone upon Cyclic Adenosine 3′:5′-Monophosphate Accumulation by Porcine Granulosa Cells 1

Ada M. Lindsey, Cornelia P. Channing

Experimental Biology and Medicine

Search results